Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A systematic review and network meta-analysis of randomized controlled trials on the treatment of trigger finger.

Created on 09 Jul 2026

Authors

Fu-An Yang, Pei-Jyuan Wu, Chin-Wen Wu, Jia-Pei Hong, Chao-Chun Huang, Hung-Chou Chen

Published in

Scientific reports. Jul 08, 2026. Epub Jul 08, 2026.

Abstract

This systematic review and network meta-analysis evaluated the comparative efficacy of various interventions for trigger finger relative to open surgery. A total of 24 randomized controlled trials involving 1,660 digits were included. In the short term, corticosteroid injection (SMD = -3.81; 95% CI: -6.09 to -1.53), hyaluronic acid injection (SMD = -3.13; 95% CI: -5.86 to -0.40), and percutaneous release combined with splint use (SMD = -3.07; 95% CI: -5.36 to -0.78) significantly reduced disease severity compared with open surgery. In the long term, corticosteroid injection (SMD = -4.49; 95% CI: -6.79 to -2.18) and hyaluronic acid injection (SMD = -4.35; 95% CI: -7.42 to -1.28) demonstrated sustained effectiveness. SUCRA rankings identified corticosteroid injection as the intervention with the highest probability of being most effective at both time points. Current evidence suggests that minimally invasive interventions, particularly corticosteroid and hyaluronic acid injections, offer superior reduction in disease severity compared to open surgery in both the short and long term.

PMID:
42420408
Bibliographic data and abstract were imported from PubMed on 09 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement